Sinovac, Bio Farma Indonesia collaborate on potential Covid-19 vaccine
Sinovac will provide Bio Farma with bulk vaccine, enabling it manufacture a minimum of 40 million doses of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
26 Aug 20
Sinovac will provide Bio Farma with bulk vaccine, enabling it manufacture a minimum of 40 million doses of…
19 Aug 20
Both Lilly and Innovent have been studying Tyvyt to treat non-squamous non-small cell lung cancer (NSCLC) and various…
17 Aug 20
The current supply agreement follows AstraZeneca’s previous agreement with Inclusive Vaccines Alliance (IVA) to supply 400 million doses…
14 Aug 20
UNION has agreed to pay up to $210m to TFF Pharmaceuticals, to support the development, regulatory approvals and…
10 Aug 20
Pfizer is expected to provide manufacturing services from its McPherson, Kansas facility to manufacture and supply Gilead’s remdesivir
05 Aug 20
The UK government and Valneva announced a joint investment to expand the Livingston facility for enhanced vaccine manufacturing…
27 Jul 20
The collaboration is aimed at developing and commercialising DS-1062, around the world, except in Japan, where Daiichi Sankyo…
27 Jul 20
The additional BARDA funding will support the expanded Phase 3 study of Moderna’s potential Covid-19 vaccine candidate mRNA-1273
24 Jul 20
Novavax has already started manufacturing the first batch of its NVX-CoV2373 at FDB's manufacturing facility in Morrisville, North…
23 Jul 20
The US government will pay $1.95bn, after receiving of the 100 million doses, and has an option to…